Inventor · disambiguated record
Bin Wu
Also filed as: WU BIN · WU BIN-NAN
18 granted patents·13 pending applications·70 citations·filing 2001–2025
91Inventor score
Files withAMGEN INC11UNIV NANYANG TECH3AGIOS PHARMACEUTICALS INC2PETTUS LIPING H2UNIV KAOHSIUNG MEDICAL2
Top patents by PatentIndex Score
31 records- 0192US10137130B2Methods of treatment of malignanciesCELGENE CORP·Filed 2016·Granted Nov 27, 2018·9 cites·16 claims
- 0290US10905772B2Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2018·Granted Feb 2, 2021·6 cites·18 claims
- 0390US9090593B2Bicyclic compounds as Pim inhibitorsWANG HUI-LING·Filed 2011·Granted Jul 28, 2015·26 cites·51 claims
- 0483US10188656B2Methods of treatment of malignanciesAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jan 29, 2019·4 cites·8 claims
- 0582US6974867B2Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizersCHIRON CORP·Filed 2001·Granted Dec 13, 2005·10 cites·4 claims
- 0680US8772480B2Inhibitors of PI3 kinase and/or mTORAMGEN INC·Filed 2012·Granted Jul 8, 2014·5 cites·25 claims
- 0780US2025121056A1Method of treating or ameliorating metabolic disorders using glp-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (gipr)AMGEN INC·Filed 2024·Application pending·0 cites
- 0879US8420649B2Pyrido[3,2-d]pyridazine-2(1H)-one compounds as p38 modulators and methods of use thereofPETTUS LIPING H·Filed 2009·Granted Apr 16, 2013·4 cites·12 claims
- 0977US7993832B2Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disordersXDX INC·Filed 2007·Granted Aug 9, 2011·5 cites·4 claims
- 1069US12214051B2Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2021·Granted Feb 4, 2025·0 cites·14 claims
- 1169US2024263210A1Methods for enzymatic peptide ligationUNIV NANYANG TECH·Filed 2023·Application pending·0 cites
- 1268US8754192B2Compositions comprising homogeneously glycosylated erythropoietinDANISHEFSKY SAMUEL J·Filed 2007·Granted Jun 17, 2014·1 cites·9 claims
- 1368US2009209560A1Anti-inflammation activity of newly synthesized xanthine derivatives kmup-1 and kmup-3UNIV KAOHSIUNG MEDICAL·Filed 2009·Application pending·0 cites
- 1467US11732266B2RNAi constructs for inhibiting ASGR1 expression and methods of use thereofAMGEN INC·Filed 2020·Granted Aug 22, 2023·0 cites·34 claims
- 1567US2023128192A1Methods for enzymatic peptide ligationUNIV NANYANG TECH·Filed 2022·Application pending·0 cites
- 1662US2022000878A1Methods of treatment of malignanciesSERVIER PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1761US2008081816A1Anti-inflammation activity of newly synthesized xanthine derivatives kmup-1 and kmup-3UNIV KAOHSIUNG MEDICAL·Filed 2006·Application pending·0 cites
- 1859US2005282766A1Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizersWU BIN·Filed 2005·Application pending·0 cites
- 1957US10870856B2RNAi constructs for inhibiting ASGR1 expression and methods of use thereofAMGEN INC·Filed 2017·Granted Dec 22, 2020·0 cites·36 claims
- 2057US2020261434A1Idh1 inhibitors for the treatment of haematological malignancies and solid tumorsAGIOS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2155US11795488B2Methods for enzymatic peptide ligationUNIV NANYANG TECH·Filed 2017·Granted Oct 24, 2023·0 cites·12 claims
- 2254US2022403378A1Light-inducible crispr/cas9 system for genome editingUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 2354US2023037966A1Source specific exosomes for determining avoidance of cancer treatment and avoidance of checkpoint inhibitor therapiesUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 2452US8455495B2Pyridazino-pyridinone compounds and methods of usePETTUS LIPING H·Filed 2009·Granted Jun 4, 2013·0 cites·15 claims
- 2552US2023078200A1RNAi CONSTRUCTS AND METHODS FOR INHIBITING LPA EXPRESSIONAMGEN INC·Filed 2020·Application pending·0 cites
- 2651US2022049252A1CHEMICALLY-MODIFIED RNAi CONSTRUCTS AND USES THEREOFAMGEN INC·Filed 2019·Application pending·0 cites
- 2749US2025276080A1Glucagon receptor agonists and conjugates to glucose-dependent insulinotropic polypeptide antagonistsAMGEN INC·Filed 2025·Application pending·0 cites
- 2843US10344060B2Potent and selective inhibitors of Nav1.7AMGEN INC·Filed 2014·Granted Jul 9, 2019·0 cites·25 claims
- 2942US9394297B2Amides as pim inhibitorsAMGEN INC·Filed 2013·Granted Jul 19, 2016·0 cites·20 claims
- 3040US9321756B2Azole compounds as PIM inhibitorsWANG HUI-LING·Filed 2012·Granted Apr 26, 2016·0 cites·16 claims
- 3134US9187486B2Bicyclic pyridazine compounds as Pim inhibitorsD AMICO DERIN C·Filed 2012·Granted Nov 17, 2015·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Bin Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →